A Global Educational Initiative for Healthcare Providers
Featuring Adi Diab, MD (Course Director); Mark M. Awad, MD, PhD; Arjun V. Balar, MD; and Nizar M. Tannir, MD, FACP
Join these clinical experts for an intimate discussion of the latest scientific evidence and future perspectives related to advances in immunotherapy across a variety of solid tumors, including bladder cancer, lung cancer, ovarian cancer, renal cell carcinoma, and skin cancer, and the potential subsequent implications for practice and patient care.
Transcripts Available in 6 Languages!
Earn 1.0 AMA PRA Cateogy I Credit™
How do advances in the field of immuno-oncology impact patient care for your practice?
This Peer-to-Peer Education Kit provides access to turnkey resources, including a Power Point Slide Presentation and a comprehensive Discussion Guide, to allow you to take the latest clinical information on immunotherapies back to your colleagues and lead important conversations on the clinical implications for your patients and practices.
Discussion Guide Available in 6 Languages!
Jointly provided by The University of Texas MD Anderson Cancer Center and ASiM CE LLC.
This activity is supported by educational grants from Pfizer, Inc and EMD Serono.